BICILLIN C-R 900 Drug Patent Profile
✉ Email this page to a colleague
When do Bicillin C-r 900 patents expire, and when can generic versions of Bicillin C-r 900 launch?
Bicillin C-r 900 is a drug marketed by King Pharms Llc and is included in one NDA.
The generic ingredient in BICILLIN C-R 900 is penicillin g benzathine; penicillin g procaine. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BICILLIN C-R 900?
- What are the global sales for BICILLIN C-R 900?
- What is Average Wholesale Price for BICILLIN C-R 900?
Summary for BICILLIN C-R 900
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | BICILLIN C-R 900 at DailyMed |
US Patents and Regulatory Information for BICILLIN C-R 900
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms Llc | BICILLIN C-R 900/300 | penicillin g benzathine; penicillin g procaine | INJECTABLE;INJECTION | 050138-003 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |